-
Campos MS, Barrionuevo M, Alferez MJ, Gomez-Ayala AE, Rodriguez-Mata MC, Lopez O (1998) Interactions among iron, calcium, phosphorus and magnesium in the nutritionally iron-deficient rat. Exp Physiol 83: 771-781.
-
Carstanjen D, Regenfus M, Müller C, Salama A (2001) Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Exp Hematol 29: 812-821.
-
Clark EM, Tobias JH, Ness AR (2006) Association between bone density and fractures in children: a systematic review and meta-analysis. Pediatrics 117: e291-297.
-
Cundy T, Horne A, Bolland M, Gamble G, Davidson J (2007) Bone formation markers in adults with mild oseogenesis imperfecta. Clin Chem 53: 1109-1114.
-
D'Amelio P, Cristofaro MA, Tamone C, Morra E, Di Bella S, Isaia G, Grimaldi A, Gennero L, Gariboldi A, Ponzetto A, Pescarmona GP, Isaia GC (2008) Role of iron metabolism and oxidative damage in postmenopausal bone loss. Bone 43: 1010-1015.
-
D'Amelio P, Di Bella S, Tamone C, Ravazzoli MG, Cristofaro MA, Di Stefano M, Isaia G (2008) HDL cholesterol and bone mineral density in normal-weight postmenopausal women: is there any possible association? Panminerva Med 50: 89-96.
-
de Ceuninck F (2008) The application of proteomics to articular cartilage: a new hope for the treatment of osteoarthritis. Joint Bone Spine 75: 376-378.
-
Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D (1999) Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145: 287-292.
-
Fonseca JE, Santos MJ, Canhão H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8: 538-542.
-
Forlino A, Tani C, Rossi A, Lupi A, Campari E, Gualeni B, Bianchi L, Armini A, Cetta G, Bini L, Marini JC (2007) Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta. Proteomics 7: 1877-1891.